Literature DB >> 31924320

Changing Trends in the Landscape of Patients Hospitalized With Acute Myocardial Infarction (2001 to 2011) (from the Worcester Heart Attack Study).

Regino Mercado-Lubo1, Jorge Yarzebski1, Darleen Lessard1, Joel Gore1, Robert J Goldberg2.   

Abstract

During the past several decades, new diagnostic tools, interventional approaches, and population-wide changes in the major coronary risk factors have taken place. However, few studies have examined relatively recent trends in the demographic characteristics, clinical profile, and the short-term outcomes of patients hospitalized for acute myocardial infarction (AMI) from the more generalizable perspective of a population-based investigation. We examined decade long trends (2001 to 2011) in patient's demographic and clinical characteristics, treatment practices, and hospital outcomes among residents of the Worcester metropolitan area hospitalized with an initial AMI (n = 3,730) at all 11 greater Worcester medical centers during 2001, 2003, 2005, 2007, 2009, and 2011. The average age of the study population was 68.5 years and 56.9% were men. Patients hospitalized with a first AMI during the most recent study years were significantly younger (mean age = 69.9 years in 2001/2003; 65.2 years in 2009/2011), had lower serum troponin levels, and experienced a shorter hospital stay compared with patients hospitalized during the earliest study years. Hospitalized patients were more likely to received evidence-based medical management practices over the decade long period under study. Multivariable-adjusted regression models showed a considerable decline over time in the hospital death rate and a significant reduction in the proportion of patients who developed atrial fibrillation, heart failure, and ventricular fibrillation during their acute hospitalization. These results highlight the changing nature of patients hospitalized with an incident AMI, and reinforce the need for surveillance of AMI at the community level.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31924320      PMCID: PMC7160648          DOI: 10.1016/j.amjcard.2019.12.009

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-01-03       Impact factor: 29.690

2.  Survival rates after heart attack improve in Canada; after stroke they remain steady.

Authors:  Barbara Kermode-Scott
Journal:  BMJ       Date:  2006-06-17

3.  Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study.

Authors:  R J Goldberg; J M Gore; J S Alpert; J E Dalen
Journal:  Am Heart J       Date:  1988-04       Impact factor: 4.749

4.  A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective.

Authors:  R J Goldberg; J Yarzebski; D Lessard; J M Gore
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

5.  Risk Factors and Trends in Incidence of Heart Failure Following Acute Myocardial Infarction.

Authors:  Jennifer Wellings; John B Kostis; Davit Sargsyan; Javier Cabrera; William J Kostis
Journal:  Am J Cardiol       Date:  2018-03-28       Impact factor: 2.778

6.  Acute coronary syndromes in the community.

Authors:  Sheila M Manemann; Yariv Gerber; Alanna M Chamberlain; Shannon M Dunlay; Malcolm R Bell; Allan S Jaffe; Susan A Weston; Jill M Killian; Jan Kors; Véronique L Roger
Journal:  Mayo Clin Proc       Date:  2015-03-18       Impact factor: 7.616

Review 7.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention.

Authors:  Kunihiro Kinjo; Hiroshi Sato; Hideyuki Sato; Yozo Ohnishi; Eiji Hishida; Daisaku Nakatani; Hiroya Mizuno; Masatake Fukunami; Yukihiro Koretsune; Hiroshi Takeda; Masatsugu Hori
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

10.  Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia.

Authors:  Joseph Hung; Tiew-Hwa Katherine Teng; Judith Finn; Matthew Knuiman; Thomas Briffa; Simon Stewart; Frank M Sanfilippo; Steven Ridout; Michael Hobbs
Journal:  J Am Heart Assoc       Date:  2013-10-08       Impact factor: 5.501

View more
  2 in total

Review 1.  Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.

Authors:  Giuseppe Boriani; Marco Vitolo; Igor Diemberger; Marco Proietti; Anna Chiara Valenti; Vincenzo Livio Malavasi; Gregory Y H Lip
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 13.081

2.  Serum GDF-15 Predicts In-Hospital Mortality and Arrhythmic Risks in Patients With Acute Myocardial Infarction.

Authors:  Qiuping Mo; Liuan Zhuo; Zhihong Liao; Rongshan Li; Yu Chen; Jianfang Geng
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.